CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 8-K Event Agreement ended
- 8-K Event Material agreement
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Delisting notice
- 8-K Event Material agreement · Agreement ended · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Material agreement
- 8-K Event Bylaws or fiscal year change · Other events
- 8-K Event Shareholder vote results
- 8-K Event Material agreement
- 8-K/A Event Executive or director change
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Delisting notice
- 10-K/A Report 10-K/A
- 8-K Event Delisting notice · Restatement · Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Executive or director change · Regulation FD disclosure · Other events
Page 4 of 22 · 427 filings